Up-regulation of twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 26, Issue 3, 2007, Pages 385-394

  Niu, R F ^a   Zhang, L ^a   Xi, G M ^a   Wei, X Y ^a   Yang, Y ^a   Shi, Y R ^a   Hao, X S ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

E cadherin; HCC; N cadherin; Twist; VEGF

Indexed keywords

CD34 ANTIGEN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; UPREGULATION;

ANTIGENS, CD; CADHERINS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED; TWIST TRANSCRIPTION FACTOR; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 35348870930     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Mironchik Y., Winnard P.T. J.r., Vesuna F., et al.: Twist Overexpression Induces In vivo Angiogenesis and Correlates with Chromosomal Instability in Breast Cancer. Cancer Res. 65(11): 10801-10809, 2005.
2. Folkman J.: Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29: 15-18, 2002.
3. Poon R.T., Lau C.P., Ho J.W., Yu W.C., Fan S.T., Wong J.: Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Clin. Cancer Res. 9: 5339-5345, 2003.
4. Carr B.I.: Hepatocellular carcinoma: current management and future trends. Gastroenterology. 127: S218-224, 2004.
5. Nor J.E., Christensen J., Mooney D.J., Polverini P.J.: Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am. J. Pathol. 154: 375-84, 1999.
6. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N.: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246: 1306-9, 1989.
7. Larue L., Bellacosa A.: Epithelial-mesenchymal transition in develop- ment and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways.Oncogene.24: 7443-7454, 2005.
8. Puisieux A., Valsesia-Wittmann S., Ansieau S.: A twist for survival and cancer progression. Br. J. Cancer. 94(1): 13-7, 2006.
9. Yang J., Mani S.A., Donaher J.L., et al.: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 118(3):277-9, 2004.
10. Kwok W.K., Ling M.T., Lee T.W., et al.: Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res. 65(12):5153-62, 2005.
11. Oda H., Tsukita S., Takeichi M.: Dynamic behavior of the cadherin-based cell-cell adhesion system during Drosophila gastrulation. Dev. Biol. 203(2): 435-50, 1998.
12. Handschuh G., Candidus S., Luber B., et al.: Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene. 18:4301-4312, 1999.
13. Birchmeier W., Behrens J.: Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta. 1198:11-26, 1994.
14. Oka H., Shiozaki H., Kobayashi K., et al.: Expression of E-Cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 53: 1696-1701, 1993.
15. Hirohashi S.: Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol. 153:333-339, 1998.
16. Nieman M.T., Prudoff R.S., Johnson K.R., Wheelock M.J.: N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell. Biol. 147:631-644, 1999.
17. Hazan R.B., Phillips G.R., Qiao R.F., Norton L., Aaronson S.A.: Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell. Biol. 148: 779-790, 2000.
18. -ΔΔCt Method. METHODS. 25: 402-408, 2001.
19. Masunaga R., Kohno H., Dhar D.K., et al.: Cyclooxygenase-2 Expression Correlates with Tumor Neovascularization and Prognosis in Human Colorectal Carcinoma Patients. Clin. Cancer Res. 6(10): 4064-4068, 2000.
20. Kyo S., Sakaguchi J., Ohno S., et al.: High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Human Pathology. 37: 431-438, 2006.
21. Wei Y., Van Nhieu J.T., Prigent S., et al.: Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Hepatology. 36(3):692-701, 2002.
22. Ihara A., Koizumi H., Hashizume R., Uchikoshi T., et al.: Expression of epithelial Cadherin and alpha- and beta-catenins in non-tumoral livers and hepatocellular carcinoma. Hepatology. 23:1441-1447, 1996.
23. Rosivatz E., Becker I., Specht K.,et al.: Differential Expression of the Epithelial-Mesenchymal Transition Regulators Snail, SIP1, and Twist in Gastric Cancer. Am. J. Pathol. 161:1881-1891, 2002.
24. Song L.B., Liao W.T., Mai H.Q.,et al.: The clinical significance of twist expression in nasopharyngeal carcinoma. Cancer Letters. 242(2):258-65, 2006.
25. Kwok W.K., Ling M.T., Lee T.W., et al. Up-Regulation of TWIST in Prostate Cancer and Its Implication as a Therapeutic Target. Cancer Res. 65: 5153-5162, 2005.
26. Gerecht-Nir S., Dazard J.E., Golan-Mashiach M., et al: Vascular gene expression and phenotypic correlation during differentiation of human embryonic stem cells. Dev. Dyn. 232(2):487-97, 2005.
27. Yamaguchi R., Yano H., Nakashima Y., Ogasawara S., Higaki K., Akiba J., Hicklin D.J., Kojiro M.: Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues. Oncol. Rep. 7:725- 729, 2000.
28. Leptin M., Grunewald B.: Cell shape changes during gastrulation in Drosophila. Development. 110(1):73-84, 1990.
29. Thisse B., Messal M., Perrin-Schmitt F.: The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. Nucleic Acids Res. 15(8):3439-53, 1987.
30. Karreth F., Tuveson D.A.: Twist Induces an Epithelial-Mesenchymal Transition to Facilitate Tumor Metastasis. Cancer Biology & Therapy. 3 (11):1058-1059, 2004.
31. Kanai Y., Ushijima S., Tsuda H., et al.: Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis. Cancer Lett. 148: 73-80, 2000.
32. Herath N.I., Leggett B.A., Macdonald G.A.: Review of genetic and epigenetic alterations in hepatocarcinogenesis. J Gastroenterol Hepatol. 21:15-21, 2006.
33. Batsche E., Muchardt C., Behrens J., Hurst H.C., Cremisi C.: RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol.18: 3647-3658, 1998.
34. Dong H.M., Liu G., Hou Y.F., Wu J., Lu J.S., Luo J.M., Shen Z.Z., Shao Z.M.: Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro. J. Cancer Res. Clin. Oncol. 24, 2006.
35. Alexander N.R., Tran N.L., Rekapally H., et al.: N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist 1. Cancer Res. 66(7):3365-9, 2006.
36. Nieman M.T., Prudoff R.S., Johnson K.R., Wheelock M.J.: N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell. Biol.147:631-644, 1999.
37. Maestro R., Dei Tos A.P., Hamamori Y., et al.: Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 13(17):2207-17, 1999.
38. Wang X., Ling M.T., Guan X. Y., et al.: Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene. 23(2):474-82, 2004.
39. Howe L.R., Watanabe O., Leonard J., Brown A.M.: Twist Is Up-Regulated in Response to Wnt1 and Inhibits Mouse Mammary Cell Differentiation. Cancer Res. 63: 1906-1913, 2003.
40. Leshem Y., Spicer D.B., Gal-Levi R., et al.: Hepatocyte growth factor (HGF) inhibits skeletal muscle cell differentiation: a role for the bHLH protein twist and the cdk inhibitor p27. J. Cell. Physiol. 184(1): 101-109, 2000.
41. Ling X., Arlinghaus R.B.: Knockdown of STAT3 Expression by RNA Interference Inhibits the Induction of Breast Tumors in Immunocompetent Mice. Cancer Res. 65(7): 2532-2536, 2005.